Showing results (91-100 of 109) with videos related to
Sort By:
Pageof 11
International Journal of Oncology|December 6, 2005
Differential expression of trypsinogen and tumor-associated trypsin inhibitor (TATI) in bladder cancerK Hotakainen, A Bjartell, A Sankila, et al.International Journal of Cancer|September 30, 1999
Concentration of free hCGbeta subunit in serum as a prognostic marker for squamous-cell carcinoma of the oral cavity and oropharynxJ Hedström, R Grenman, H Ramsay, et al.Oncology|April 2, 2011
Anaplastic and poorly differentiated thyroid carcinoma: therapeutic strategies and treatment outcome of 52 consecutive patientsP Siironen, J Hagström, H O Mäenpää, et al.Oncology|July 8, 1999
Sialyl Tn is a frequently expressed antigen in colorectal cancer: No correlation with patient prognosisM Lundin, S Nordling, P J Roberts, et al.British Journal of Cancer|August 1, 1986
Tumour-associated trypsin inhibitor, TATI, in patients with pancreatic cancer, pancreatitis and benign biliary diseasesC Haglund, M L Huhtala, H Halila, et al.Thrombosis Research|January 1, 2021
Levels of the cancer biomarker CA 19-9 are associated with thrombin generation in plasma from treatment-naïve pancreatic cancer patientsN Mattila, Y Hisada, B Przybyla, et al.Journal of Clinical Pathology|August 29, 2006
Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancerN Linder, C Haglund, M Lundin, et al.British Journal of Cancer|May 18, 2001
The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activationA Paju, T Sorsa, T Tervahartiala, et al.Biochemical Pharmacology|August 28, 2016
Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemiaA Österroos, M Kashif, C Haglund, et al.Annales Chirurgiae Et Gynaecologiae|January 1, 1996
Laparoscopic cholecystectomy: the Finnish experienceJ Ovaska, I Airo, C Haglund, et al.Pageof 11